comparemela.com

Page 10 - Afrpt News Today : Breaking News, Live Updates & Top Stories | Vimarsana

RPT Realty (NYSE:RPT) Shares Pass Above 200-Day Moving Average of $9 83

RPT Realty (NYSE:RPT – Get Free Report)’s stock price passed above its 200-day moving average during trading on Wednesday . The stock has a 200-day moving average of $9.83 and traded as high as $10.96. RPT Realty shares last traded at $10.76, with a volume of 421,332 shares traded. Analysts Set New Price Targets A […]

Top Weekly ETFs: Carbon Offset ETF KSET Leads

RPT Realty (NYSE:RPT) Share Price Crosses Above Two Hundred Day Moving Average of $9 82

RPT Realty (NYSE:RPT – Get Rating)’s share price crossed above its 200-day moving average during trading on Monday . The stock has a 200-day moving average of $9.82 and traded as high as $9.85. RPT Realty shares last traded at $9.81, with a volume of 889,473 shares traded. Wall Street Analysts Forecast Growth Several analysts […]

FDA OKs Elevidys As First Gene Therapy To Treat Duchenne Muscular Dystrophy

Sarepta Therapeutics, Inc. announced Friday that the U.S. Food and Drug Administration or FDA has accelerated approval of ELEVIDYS (delandistrogene moxeparvovec-rokl) for the treatment of ambulatory pediatric patients aged 4 through 5 years with Duchenne muscular dystrophy (DMD) with a confirmed mutation in the DMD gene.

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.